Alphatec (NSDQ:ATEC) said it agreed to pay $49 million over 7 years to settle a legal dispute with OrthoTec and beat Wall Street’s forecast for its 4th-quarter earnings.
2013
Cantel Medical slides despite Street-beating Q2
Cantel Medical (NYSE:CMN) shares are down nearly 4% this morning after the medical device company reported its fiscal 2nd-quarter results.
Biolase cuts costs ahead of a potential sale, posts losses in Q4
Kinetic Concepts, LifeCell, Systagenix trio posts red ink in Q4
The newly formed medtech alliance comprised of Kinetic Concepts, LifeCell and Systagenix posted collective figures that put the group in the red for Q4, a recent SEC filing shows.
NuVasive shares jump on Street-beating Q4 numbers
NuVasive Inc. (NSDQ:NUVA) shares gained nearly 8% today after the medical device company reported beating expectations with its 4th-quarter earnings as it swung to black ink.
State AGs subpoena Endo Health over pelvic mesh products
Endo Health Solutions (NSDQ:ENDP) said its pelvic mesh products are under investigation by the attorneys general from several states including California.
Diabetes: Insulet boosts sales, slashes losses, notes Mass. state inquiry
HeartWare slides on Q4, 2013 misses
Investors punished HeartWare International (NSDQ:HTWR) today for missing expectations with its 4th-quarter and full-year results, paring some 3% from HTWR shares.
NxStage Medical tops Q4, 2013 estimates
NxStage Medical (NSDQ:NXTM) shares rose today after the medical device company said it just beat estimates with its results for the 4th quarter and last year.
Layoffs ahead for LeMaitre Vascular despite record Q4 sales
LeMaitre Vascular (NSDQ:LMAT) said it plans to lay off about 10% of its workforce, or about 30 employees, even as it comes off of a record sales performance during the 4th quarter.
